Drug Repurposing Intelligence
We identify hidden links between existing drugs and new therapeutic indications.
Drug repurposing intelligence
We find overlooked therapeutic opportunities before they become obvious.
Perspica Labs is a research company focused on drug repurposing opportunities that have not yet been organized into obvious market language.
What we build
We build computational systems for drug repurposing, lifecycle extension, and evidence-driven opportunity discovery.
Our internal work connects public biomedical data, patent-aware reasoning, and low-cost validation pathways into a disciplined opportunity discovery process.
What We Do
We identify hidden links between existing drugs and new therapeutic indications.
We analyze extension potential that originators or markets have not yet fully recognized.
We map prior art, claim scope, experimental feasibility, and licensing-out potential together.
We design cell-based, mechanism-focused, and biomarker-informed validation strategies before large clinical commitments.
Internal platform
Prometheon is Perspica Labs' internal engine for drug repurposing discovery.
It is designed to surface non-obvious therapeutic hypotheses from fragmented biomedical, regulatory, and patent signals.
We do not simply search for what is already known. We look for the spaces where biology, ownership, validation cost, and market timing quietly align.
Opportunity criteria
Evidence strong enough to deserve a next experiment.
Validation path small enough to test before heavy capital is committed.
Rights structure clear enough to support a serious licensing conversation.
Confidential partnership inquiries
Confidential inquiries are welcome.
contact@perspicalabs.com